1 year return (CAGR)
-40.50%
Phathom Pharmaceuticals Inc Exchange (NASDAQ, USD)
PHAT
6.99
-0.78 (-9.99%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-16.76%
5 year return (CAGR)
-26.77%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
565.09M
Price/Sales
2.36
Ent value
1.05B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
6.29
EPS growth
-4.82%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 7.73 |
| Daily high | 7.75 |
| Daily low | 6.98 |
| Daily Volume | 1.04M |
| All-time high | 54.60 |
| 1y analyst estimate | 21.50 |
| Beta | 0.50 |
| EPS (TTM) | -1.18 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 3 Mar 2026 |
Downside potential
Loading...
Downside potential data
| PHAT | S&P500 | |
| Current price drop from All-time high | -87.21% | -1.29% |
| Highest price drop | -95.81% | -56.47% |
| Date of highest drop | 8 May 2025 | 9 Mar 2009 |
| Avg drop from high | -64.15% | -10.68% |
| Avg time to new high | 91 days | 12 days |
| Max time to new high | 1582 days | 1805 days |
News
